Literature DB >> 2784837

Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA.

Y X Feng1, D L Hatfield, A Rein, J G Levin.   

Abstract

An in vitro system to assay translational readthrough of the UAG termination codon at the murine leukemia virus (MuLV) gag-pol junction was developed by using rabbit reticulocyte lysates programmed by SP6-generated Moloney MuLV gag-pol mRNA. Under conditions in which the suppressor activity of the lysate was dependent on addition of tRNA, it could be shown that readthrough synthesis was stimulated to approximately the same extent by equivalent amounts of tRNA from MuLV-infected and uninfected NIH 3T3 cells. Analysis of glutamine tRNA, which mediates suppression in vivo, showed that the level of glutamine acceptor activity and the chromatographic profile of glutamine isoacceptors were unchanged following virus infection. On the basis of these results, we conclude that the suppressor tRNA occurs normally within the tRNA population of uninfected cells and need not be induced in response to virus infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784837      PMCID: PMC250668     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting.

Authors:  T Jacks; H E Varmus
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

2.  Retroviral gag gene amber codon suppression is caused by an intrinsic cis-acting component of the viral mRNA.

Authors:  A T Panganiban
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

3.  Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli.

Authors:  S C Hu; D L Court; M Zweig; J G Levin
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

Authors:  J G Levin; R J Crouch; K Post; S C Hu; D McKelvin; M Zweig; D L Court; B I Gerwin
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

6.  Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

Authors:  A Rein; M R McClure; N R Rice; R B Luftig; A M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Natural UAG suppressor glutamine tRNA is elevated in mouse cells infected with Moloney murine leukemia virus.

Authors:  Y Kuchino; H Beier; N Akita; S Nishimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Glutamine starvation of murine leukaemia virus-infected cells inhibits the readthrough of the gag-pol genes and proteolytic processing of the gag polyprotein.

Authors:  I Gloger; A Panet
Journal:  J Gen Virol       Date:  1986-10       Impact factor: 3.891

9.  Selenocysteine's mechanism of incorporation and evolution revealed in cDNAs of three glutathione peroxidases.

Authors:  G T Mullenbach; A Tabrizi; B D Irvine; G I Bell; J A Tainer; R A Hallewell
Journal:  Protein Eng       Date:  1988-09

Review 10.  Stop making sense: or Regulation at the level of termination in eukaryotic protein synthesis.

Authors:  R P Valle; M D Morch
Journal:  FEBS Lett       Date:  1988-08-01       Impact factor: 4.124

View more
  23 in total

Review 1.  Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs.

Authors:  H Beier; M Grimm
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

2.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 3.  Eucaryotic codes.

Authors:  F Caron
Journal:  Experientia       Date:  1990-12-01

4.  Bipartite signal for read-through suppression in murine leukemia virus mRNA: an eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot.

Authors:  Y X Feng; H Yuan; A Rein; J G Levin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Selective and nonselective packaging of cellular RNAs in retrovirus particles.

Authors:  Samuel J Rulli; Catherine S Hibbert; Jane Mirro; Thoru Pederson; Shyam Biswal; Alan Rein
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

6.  Suppression of UAA and UGA termination codons in mutant murine leukemia viruses.

Authors:  Y X Feng; J G Levin; D L Hatfield; T S Schaefer; R J Gorelick; A Rein
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.

Authors:  Jennifer A Seamon; Kathryn S Jones; Christina Miller; Monica J Roth
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Effects of blocking individual maturation cleavages in murine leukemia virus gag.

Authors:  Masamichi Oshima; Delphine Muriaux; Jane Mirro; Kunio Nagashima; Kelly Dryden; Mark Yeager; Alan Rein
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers.

Authors:  Catherine S Hibbert; Jane Mirro; Alan Rein
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.